"United States Pharmaceuticals & Healthcare Report Q1 2014" Published
Despite the botched rollout of the Affordable Care Act, we expect reform of the US healthcare system to continue over the coming years, mainly due to the need to control growth in spending on medical services. Implementation will not be smooth due to the law's numerous opponents. We maintain that 'Obamacare' will bring only minor commercial upside to pharmaceutical companies.
View full press release